MRMehboob Ahmed Rehan

Mehboob Ahmed Rehan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mehboob Ahmed Rehan has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Successful Treatment of Lactobacillus rhamnosus Endocarditis With Intravenous Daptomycin: A Case Report and Literature Review

    by Mehboob A. Rehan, J. Todd Bagwell, S. Blake Wachter, Sandeep Singh Jubbal

    Lactobacilli are Gram‐positive, facultatively aerobic, rod‐shaped bacteria that are a normal part of the human microbiota and rarely cause infections in immunocompetent hosts. Lactobacillus casei and Lactobacillus rhamnosus are the most common human pathogens within this genus and are also frequently used in probiotics. Both species are inherently resistant to vancomycin, and penicillin—sometimes in combination with aminoglycosides—remains the primary treatment for infections caused by these organisms. Management becomes particularly challenging in patients with severe penicillin allergies, such as anaphylaxis. Although daptomycin has demonstrated in vitro activity against these pathogens, clinical data on its use are limited. Here, we present a case of Lactobacillus rhamnosus endocarditis successfully treated with 6 weeks of intravenous daptomycin.

  • Open Access

    Retrospective Analysis of the Clinical Significance of Positive Blood Cultures in the Emergency Department: A Single-Center Study

    by Farha Ahmed Karlath, Mehboob Ahmed Rehan, Annie Geiger, Michael J Mitchell, Sami Arnaout, Thomas C Greenough, Richard T Ellison

    Background: There have been major advances in blood culture technology in the last decade, with both faster and more sensitive pathogen detection as well as more precise species identification. We have reassessed the results of positive blood cultures in this new clinical microbiology era with a focus on contaminant identification. Methods: A retrospective study was conducted including all patients with a blood culture collected in 2 UMass Memorial Health emergency departments from September 2019 through April 2020. Contaminants were identified based on standard clinical microbiology laboratory criteria and independent retrospective review by 3 infectious disease (ID) physicians and an ID fellow. Results: Of 5673 blood samples obtained, 5661 were analyzed after 12 were deemed inconclusive by the ID physician review. Blood culture contaminants accounted for 22.5% of the positive blood cultures. Staphylococcus epidermidis was the most frequent contaminant (33.4%), while Escherichia coli was the most frequent pathogen (21%) causing true bacteremia. Coagulase-negative staphylococci remain the most frequent cause of blood culture contamination with S epidermidis being the most common. The Staphylococcus species S auricularis, S caprae, S lentus, S pseudointermedius, S saccharolyticus, and S warneri were all determined to be contaminants in 100% of cases. Conclusions: The improvements in clinical laboratory technology enable better discrimination of the relative pathogenicity of differing coagulase-negative staphylococci species.


  • Open Access

    Calcium Alkali Thiazide Syndrome: What We Need to Know

    by Mehboob A Rehan, Asma Rashid, Kenneth Krell, Cristina Gabutti, Reema Singh

    Depending on each institution's laboratory test, mean serum calcium levels range between 8.8 and 10.8 mg/dL and hypercalcemia is defined as two standard deviations above the mean. According to recent epidemiological studies, 90% of cases of hypercalcemia are due to hyperparathyroidism or malignancy. Milk Alkali syndrome (MAS) also known as Calcium Alkali syndrome (CAS) is the third biggest cause of hypercalcemia, but its incidence seems to be higher than previously thought. Here we present a case of Calcium Alkali Thiazide syndrome (CATS) in a 57-year-old female who was on calcium and vitamin D supplements (after parathyroidectomy) while also taking thiazide diuretic for hypertension. She was brought to the ED with nausea, vomiting, confusion, difficulty walking along with numbness in extremities. She had parathyroidectomy three weeks ago. During history taking, patient reported intake of calcium carbonate 1 g three times daily, calcitriol 0.5 mcg twice daily, cholecalciferol (vitamin D3) 10,000 units once daily, chlorthalidone 25 mg once daily and irbesartan 300 mg once daily. At admission, her calcium level was 23 mg/dL, ionized calcium 12.03 mg/dL, pH was 7.59 and HCO3 was 33. She was in renal failure with creatinine of 1.9 mg/dL (baseline 0.8 mg/dL). Her parathyroid hormone (PTH) level was 0. A diagnosis of CATS was made. She was treated with intravenous fluids and furosemide and discharged home on hospital day 5 after her calcium and creatinine levels normalized. A triad of hypercalcemia, acute kidney injury and metabolic alkalosis comprises MAS. Traditional MAS was caused by "Sippy diet" (containing milk and alkali) used for the treatment of peptic ulcer disease. Over the decades, the same triad of symptoms occurred in patients using excess calcium and vitamin D, hence changing the name to CAS. A subset of patients at risk for CAS also use thiazide diuretics for hypertension, making them more vulnerable to hypercalcemia and acute kidney injury. In such subset of patients, it is preferable to use the term CATS rather than MAS or CAS.